PREVIOUS QUESTION:

 

NEXT QUESTION:

 

What is the first step in treating chronic myelogenous leukemia?

ANSWER

Your doctor will decide on a treatment plan based on the stage of your disease. You'll likely start off with a type of drug called a tyrosine kinase inhibitor (TKI). It blocks a protein called tyrosine kinase, which is made by the BCR-ABL gene and plays a role in the growth of abnormal blood cells.

SOURCES:

American Cancer Society: "Treatment of Chronic Myeloid Leukemia by Phase."

The Leukemia & Lymphoma Society: "Chronic Myelogenous Leukemia."

Goldman, L. and Ausiello, D., eds.  , 23rd ed. Saunders Elsevier; 2007. Cecil Medicine

Baccarani, M.  , May 4, 2009. Annals of Oncology

FDA website.

ARIAD Pharmaceuticals Inc.

Reviewed by Laura J. Martin on January 3, 2018

SOURCES:

American Cancer Society: "Treatment of Chronic Myeloid Leukemia by Phase."

The Leukemia & Lymphoma Society: "Chronic Myelogenous Leukemia."

Goldman, L. and Ausiello, D., eds.  , 23rd ed. Saunders Elsevier; 2007. Cecil Medicine

Baccarani, M.  , May 4, 2009. Annals of Oncology

FDA website.

ARIAD Pharmaceuticals Inc.

Reviewed by Laura J. Martin on January 3, 2018

NEXT QUESTION:

What are tyrosine kinase inhibitors (TKI) used to treat chronic myelogenous leukemia?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.

    Other Answers On: